Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.49 |
| ▸ | HTT | P42858 | 4/20 | 0.49 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.46 |
| ▸ | APAF1 | O14727 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2867039 | 0.83 | EGLN3 (0.62) | EGLN3TDP1MAPK1SMN1; SMN2HTT | |
| SCHEMBL432106 | 0.81 | EGLN3 (0.53) | EGLN3TDP1MAPK1SMN1; SMN2HTT | |
| SCHEMBL6316254 | 0.81 | ASAH1 (0.54) | EGLN3SMN1; SMN2ASAH1NPC1ALOX15 | |
| SCHEMBL2841675 | 0.79 | EGLN3 (0.61) | EGLN3TDP1MAPK1SMN1; SMN2HTT | |
| SCHEMBL8146665 | 0.79 | MTNR1A (0.64) | EGLN3TDP1MAPK1SMN1; SMN2HTT | |
| SCHEMBL6849673 | 0.77 | TDP1 (0.66) | EGLN3TDP1SMN1; SMN2HTTLMNA | |
| SCHEMBL17213626 | 0.76 | MAPT (0.44) | MAPK1HTTLMNAMAPTALDH1A1 | |
| SCHEMBL2413245 | 0.75 | MAPK1 (0.50) | EGLN3TDP1MAPK1SMN1; SMN2HTT | |
| SCHEMBL10454788 | 0.74 | EGLN3 (0.66) | EGLN3TDP1MAPK1SMN1; SMN2HTT | |
| SCHEMBL3161153 | 0.74 | TDP1 (0.84) | EGLN3TDP1MAPK1SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7582684-B2 | Macroporous ion exchange resins | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-09-01 | — | — | US | claimed |
| US-12630582-B2 | Method for biomaterial purification and kits thereof | Life Technologies Corporation (US) | 2026-05-19 | — | — | US | disclosed |
| US-20250367610-A1 | Block Copolymers Grafted to Porous Polymeric Substrate | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4543575-A1 | BLOCK COPOLYMERS GRAFTED TO POROUS POLYMERIC SUBSTRATE | Solventum Intellectual Properties Company (US) | 2025-04-30 | — | — | EP | disclosed |
| EP-2588219-B1 | FILTER PLATE ARTICLE HAVING A WATER-ABSORBENT FILTER ASSEMBLY | NEOGEN FOOD SAFETY US HOLDCO CORP (US) | 2024-05-29 | — | — | EP | disclosed |
| US-20240059731-A1 | Method for Biomaterial Purification and Kits Thereof | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-02-22 | — | — | US | disclosed |
| US-20240010674-A1 | A FILTRATION UNIT AND A METHOD FOR BIOMATERIAL PURIFICATION | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-01-11 | — | — | US | disclosed |
| WO-2023248020-A1 | BLOCK COPOLYMERS GRAFTED TO POROUS POLYMERIC SUBSTRATE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-12-28 | — | — | WO | disclosed |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| EP-4255917-A1 | A FILTRATION UNIT AND A METHOD FOR BIOMATERIAL PURIFICATION | 3M Innovative Properties Company (US) | 2023-10-11 | — | — | EP | disclosed |
| US-20070154703-A1 | FUNCTIONALIZED SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY | 2007-07-05 | — | — | US | disclosed |
| WO-2007075442-A2 | METHOD OF MAKING MACROPOROUS ANION EXCHANGE RESINS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-07-05 | — | — | WO | disclosed |
| US-20070142590-A1 | Method of making macroporous anion exchange resins | 3M INNOVATIVE PROPERTIES COMPANY | 2007-06-21 | — | — | US | disclosed |
| EP-1750839-A1 | MACROPOROUS ION EXCHANGE RESINS | 3M Innovative Properties Company (US) | 2007-02-14 | — | — | EP | disclosed |
| US-7098253-B2 | particles of hydrophilic, crosslinked copolymers of N,N'-alkylenebis(meth)acrylamide and a sulfonated N,N'-alkylene bisacrylic amide; chromatographic columns, composite materials, filters; large furface area, ease of manufacture, low material cost, variety of fiber texture, densities | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-08-29 | — | — | US | disclosed |
| WO-2005115618-A1 | MACROPOROUS ION EXCHANGE RESINS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-12-08 | — | — | WO | disclosed |
| US-20050261384-A1 | MACROPOROUS ION EXCHANGE RESINS | 3M INNOVATIVE PROPERTIES COMPANY | 2005-11-24 | — | — | US | disclosed |
| US-20050261385-A1 | Macroporous ion exchange resins | 3M INNOVATIVE PROPERTIES COMPANY | 2005-11-24 | — | — | US | disclosed |
| US-6590094-B2 | Methacrylate resin for use as tool in genetic analysis | BAYER AKTIENGESELLSCHAFT (DE) | 2003-07-08 | — | — | US | disclosed |
| US-20020106659-A1 | Methacrylate resin for use as tool in genetic analysis | BAYER AKTIENGESELLSCHAFT (DE) | 2002-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240059731-A1 | Method for Biomaterial Purification and Kits Thereof | BMP2, ADM2, PLOD3 | EGLN3 2504/4885TDP1 1840/4885MAPK1 4378/4885 |
| US-12630582-B2 | Method for biomaterial purification and kits thereof | CD68, FIBP, BMP2 | EGLN3 4193/4885TDP1 661/4885MAPK1 2453/4885 |
| US-20240010674-A1 | A FILTRATION UNIT AND A METHOD FOR BIOMATERIAL PURIFICATION | CD68, PLAUR, BMP2 | EGLN3 4570/4885TDP1 4162/4885MAPK1 2008/4885 |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | GNPDA1, GDA, PGLS | EGLN3 2534/4885TDP1 668/4885MAPK1 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.